Brief: Bcal Diagnostics Receives Firm Commitments To Raise A$10.5 Million
03/06/2024 02:37
June 3 (Reuters) - BCAL Diagnostics Ltd BDX.AX :
* RECEIVES FIRM COMMITMENTS TO RAISE A$10.5 MILLION
* PLACEMENT AT AN OFFER PRICE OF A$0.10 PER NEW SHARE
Further company coverage: BDX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BCAL Diagnostics
See all newsAustralia's Genetic Signatures urges largest stakeholder to clarify merger intentions; shares rise
Brief: BCAL Diagnostics Introduces Avantect Multi-Cancer Early Detection Test
Brief: BCAL Diagnostics Clarifies Of Bcal's Position In Relation To Genetic Signatures
Brief: Genetic Signatures Requested BCAL Diagnostics To Clarify Details Of Shareholdings, Associates In Co
Brief: BCAL To Acquire Shares In Genetic Signatures